SRP was effective in reducing IL-1β total amounts (Figure 1) in both moderate and deep sites (p < 0.001 for Grade C and p < 0.05 for Grade B, respectively) and TNF-α levels (Figure 2) in deep sites (p < 0.05) of both periodontitis groups. This evidence concerns the gene TNF and periodontitis.